[
  {
    "title": "PODD Stock Gains Following the Launch of Omnipod 5 in Australia",
    "published": 1742574960
  },
  {
    "title": "Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers",
    "published": 1742547961
  },
  {
    "title": "PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5",
    "published": 1742488860
  },
  {
    "title": "LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day",
    "published": 1742473380
  },
  {
    "title": "Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data",
    "published": 1742464483
  },
  {
    "title": "Insulet\u2019s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod\u00ae 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections",
    "published": 1742414460
  },
  {
    "title": "3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan",
    "published": 1742396580
  },
  {
    "title": "Insulet Announces Pricing of Senior Notes Due 2033",
    "published": 1742329920
  },
  {
    "title": "Insulet Chief Technology Officer Mark Field leaves",
    "published": 1742308547
  },
  {
    "title": "Insulet Expands Omnipod\u00ae 5 to Four More International Markets",
    "published": 1742292300
  },
  {
    "title": "From Injections to Innovation \u2013 Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod\u00ae 5 in Adults and Children with Type 1 Diabetes",
    "published": 1742292000
  },
  {
    "title": "Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease",
    "published": 1741715794
  },
  {
    "title": "Robinhood initiated, MongoDB downgraded: Wall Street\u2019s top analyst calls",
    "published": 1741358484
  },
  {
    "title": "Tandem\u2019s insulin pump tech wins FDA nod for Type 2 diabetes",
    "published": 1740656959
  },
  {
    "title": "Reflecting On Patient Monitoring Stocks\u2019 Q4 Earnings: DexCom (NASDAQ:DXCM)",
    "published": 1740647109
  },
  {
    "title": "Medtronic Stock Gets IBD Rating Lift",
    "published": 1740513120
  }
]